{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-099762","form_type":"8-K","ticker":"DRIO","cik":"0001533998","company_name":"DarioHealth Corp.","filed_at":"2024-09-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.421458+00:00","generated_at":"2026-05-31T04:53:09.933547+00:00","sec_items":["3.03","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"DarioHealth extends Series B-3 mandatory conversion period and increases dividends","bullets":["Mandatory conversion period extended from 15 to 18 months from original issue date.","Dividends increased: 10% for fifth full quarter and 25% for sixth quarter from closing.","No additional securities were issued or sold as a result of the amendment.","Amendment effective September 11, 2024, approved by majority of preferred stock holders."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-099762","json":"https://secwatch.observer/filing/0001104659-24-099762.json","markdown":"https://secwatch.observer/filing/0001104659-24-099762.md","text":"https://secwatch.observer/filing/0001104659-24-099762.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533998/000110465924099762/0001104659-24-099762-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533998/000110465924099762/tm2418444d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T04:53:09.933547+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}